{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:08:05Z","timestamp":1764281285594,"version":"3.46.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022MH297"],"award-info":[{"award-number":["ZR2022MH297"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.anndiagpath.2025.152556","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:08:57Z","timestamp":1756192137000},"page":"152556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnostic challenges and considerations in CD30-negative classical Hodgkin lymphoma from biopsy specimens"],"prefix":"10.1016","volume":"80","author":[{"given":"Yu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaosheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152556_bb0005","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.anndiagpath.2025.152556_bb0010","article-title":"Anagnostopoulos. The 5th edition of the world health organization classification of haematolymphoid tumours:lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000001368","article-title":"Practical approaches on CD30 detection and reporting in lymphoma diagnosis","volume":"44","author":"Xu","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5858\/arpa.2021-0338-RA","article-title":"CD30+ lymphoproliferative disorders as potential candidates for CD30-targeted therapies","volume":"146","author":"Schwarting","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0025","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1200\/JCO.20.01342","article-title":"Anti-CD30 CAR-T cell therapy in relapsed and refractory Hodgkin lymphoma","volume":"38","author":"Ramos","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0030","series-title":"CD30[EB\/OL]","first-page":"07","article-title":"QC N Control N-IQ","volume":"5","year":"2022"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0035","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1111\/cas.15874","article-title":"CD30 induces reed-Sternberg cell-like morphology and chromosomal instability in classic Hodgkin lymphoma cell lines","volume":"114","author":"Watanabe","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/his.14910","article-title":"CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy","volume":"83","author":"Marques-Piubelli","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216616","article-title":"CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy","volume":"583","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0050","first-page":"287","article-title":"Pay attention to the detection and evaluation of CD30 in pathological diagnosis of lymphoma","volume":"51","author":"Zhang","year":"2022","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-022-05054-9","article-title":"Anti-CD30 antibody-drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives","volume":"102","author":"Prince","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100949","article-title":"A review of pathobiology and therapies for classic Hodgkin lymphoma","volume":"55","author":"Khan","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0065","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.2020007507","article-title":"Mutational landscape of gray zone lymphoma","volume":"137","author":"Sarkozy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1349-7006.2000.tb00909.x","article-title":"The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(\u2212) cases in Japanese population","volume":"91","author":"Kuze","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.prp.2014.06.011","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma with zonal expansion of fibroblastic reticulum cells and infiltration by a subpopulation of myeloperoxidase positive histiocytes","volume":"210","author":"Su\u00e1rez-Vilela","year":"2014","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.7150\/jca.13107","article-title":"CD20 over-expression in Hodgkin-reed-Sternberg cells of classical Hodgkin lymphoma: the neglected quest","volume":"6","author":"Benharroch","year":"2015","journal-title":"J Cancer"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12288-021-01517-7","article-title":"Patients with classical Hodgkin lymphoma with less than 10.5 CD20-positive reed-Sternberg cells in 10 high-power fields have better prognosis","volume":"38","author":"Lacet","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0377-4929.44952","article-title":"CD20 positivity in classical Hodgkin\u2019s lymphoma: diagnostic challenge or targeting opportunity","volume":"52","author":"Barakzai","year":"2009","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0095","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/modpathol.3800227","article-title":"Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin\u2019s lymphoma","volume":"17","author":"Garc\u00eda-Cos\u00edo","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0100","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0105","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1080\/10428190600667721","article-title":"Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin\u2019s lymphoma","volume":"47","author":"Feuerborn","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0110","first-page":"199","article-title":"Evaluation of the prognostic importance of c-Myc and Bcl-2 expressions and the presence of Epstein-Barr virus in classical Hodgkin lymphoma","volume":"34","author":"Kili\u00e7arslan","year":"2018","journal-title":"Turk Patoloji Derg"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0115","first-page":"926","article-title":"Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma","volume":"36","author":"Shi","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0120","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/sj.onc.1210861","article-title":"A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development","volume":"27","author":"Yin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0125","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1074\/jbc.M115.713099","article-title":"The stress-responsive gene ATF3 mediates dichotomous UV responses by regulating the Tip60 and p53 proteins","volume":"291","author":"Cui","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2023.101514","article-title":"Hodgkin lymphoma: a disease shaped by the tumor micro- and macroenvironment","volume":"36","author":"Masel","year":"2023","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.anndiagpath.2025.152556_bb0135","doi-asserted-by":"crossref","first-page":"32088","DOI":"10.18632\/oncotarget.8525","article-title":"TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth","volume":"7","author":"Shen","year":"2016","journal-title":"Oncotarget"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:04:08Z","timestamp":1764281048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":27,"alternative-id":["S1092913425001212"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152556","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic challenges and considerations in CD30-negative classical Hodgkin lymphoma from biopsy specimens","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152556"}}